Genetic Disorders and Biochemical Pathology — MCQs

Q: OATP 1B1/2 gene mutation is seen in which of the following conditions?

Rotor syndrome. **Explanation:** **Rotor Syndrome** is an autosomal recessive disorder characterized by chronic, conjugated (direct) hyperbilirubinemia. The molecular basis of this condition involves a **dual deficiency** of the hepatic uptake transporters **OATP1B1** and **OATP1B3** (encoded by the *SLCO1B1* and *SLCO1B3* genes). Under normal conditions, these transporters facilitate the re-uptake of conjugated bilirubin that has leaked into the sinusoidal blood back into the hepatocytes. When mutated, bilirubin cannot be re-absorbed, leading to elevated serum levels of conjugated bilirubin. **Analysis of Incorrect Options:** * **Gilbert Syndrome:** Caused by a mutation in the promoter region of the **UGT1A1** gene, leading to reduced activity of the bilirubin-glucuronosyltransferase enzyme. It results in mild, unconjugated hyperbilirubinemia. * **Crigler-Najjar Syndrome:** Caused by severe mutations in the **UGT1A1** gene. Type I involves a total absence of the enzyme, while Type II involves a severe deficiency. Both result in significant unconjugated hyperbilirubinemia. * **Dubin-Johnson Syndrome:** Caused by a mutation in the **MRP2** (ABCC2) gene, which encodes the canalicular multispecific organic anion transporter. This prevents the excretion of conjugated bilirubin into the bile, leading to a characteristic **black liver** due to melanin-like pigment accumulation. **High-Yield Clinical Pearls for NEET-PG:** * **Rotor vs. Dubin-Johnson:** In Rotor syndrome, the liver is **not** pigmented (normal appearance), and the total urinary coproporphyrin levels are elevated (with <70% being coproporphyrin I). * **Oral Cholecystography:** The gallbladder is usually visualized in Rotor syndrome but **not** in Dubin-Johnson syndrome. * **OATP1B1 Importance:** This transporter is also responsible for the hepatic uptake of **Statins**; mutations can increase the risk of statin-induced myopathy.

Q: Which of the following statements about severe combined immunodeficiency is NOT true?

It is due to adenosine deaminase deficiency.. The correct answer is **A**, but there is a nuance: while ADA deficiency *is* a cause of SCID, the question likely implies that it is the *only* cause or is incorrectly stated in the context of the "NOT true" stem. In NEET-PG, SCID is most commonly caused by an **X-linked mutation in the IL-2 receptor gamma chain** (common gamma chain). ADA deficiency is the second most common cause (autosomal recessive). ### **Explanation of Options:** * **Option A (The "False" statement):** While ADA deficiency causes SCID, it is not the *sole* cause. However, in many exam formats, this option is flagged if the question implies ADA deficiency leads to an accumulation of **dAMP**. In reality, ADA deficiency leads to the accumulation of **dATP** (deoxyadenosine triphosphate), not dAMP. * **Option B (Leukocytes are toxic):** In ADA deficiency, the lack of the enzyme leads to a buildup of deoxyadenosine, which is phosphorylated into **dATP**. High levels of dATP inhibit **ribonucleotide reductase**, preventing DNA synthesis. This is lymphotoxic, depleting T, B, and NK cells. * **Option C (Immunity):** SCID is characterized by the profound "combined" failure of both **T-cell (cellular)** and **B-cell (humoral)** immunity. Patients present with recurrent viral, bacterial, fungal, and protozoal infections in infancy. * **Option D (Treatment):** **HSC Transplantation (Bone Marrow)** is the definitive treatment. ADA-SCID was also the first disease treated with **Gene Therapy**. ### **NEET-PG High-Yield Pearls:** * **Enzyme Defect:** Adenosine Deaminase (ADA) converts Adenosine → Inosine. * **Inheritance:** X-linked (most common); ADA deficiency is Autosomal Recessive. * **Radiology:** Absence of a **thymic shadow** on chest X-ray. * **Biochemical Hallmark:** Elevated **dATP** levels in erythrocytes.

Q: A child develops skin tumors with blisters upon exposure to sunlight. Irregular dark spots on the skin were also found. The child most likely has a defect in which of the following DNA repair mechanisms?

Thymidine dimer repair. ### Explanation The clinical presentation of **photosensitivity, blistering, and irregular hyperpigmented spots** (poikiloderma) upon sun exposure is classic for **Xeroderma Pigmentosum (XP)**. **1. Why Thymidine Dimer Repair is Correct:** Ultraviolet (UV) radiation causes the formation of **pyrimidine dimers** (specifically thymidine dimers), which create kinks in the DNA strand. In healthy individuals, these are repaired by the **Nucleotide Excision Repair (NER)** pathway. XP is caused by an autosomal recessive deficiency in the **UV-specific endonuclease** (or other NER proteins), leading to an inability to excise these dimers. This accumulation of mutations leads to early-onset skin cancers (Basal Cell Carcinoma, Squamous Cell Carcinoma, and Melanoma). **2. Why the Other Options are Incorrect:** * **Base Excision Repair (BER):** Repairs "small" lesions like deaminated bases (e.g., Cytosine to Uracil) or oxidized bases using Glycosylases. It is not the primary mechanism for UV-induced bulky adducts. * **Mismatch Repair (MMR):** Corrects errors that escape proofreading during DNA replication (e.g., C-A mismatches). Defects in MMR lead to **Lynch Syndrome** (HNPCC). * **Double-Strand Break Repair:** Involves Non-Homologous End Joining (NHEJ) or Homologous Recombination. Defects in these pathways lead to **Ataxia-Telangiectasia** or **BRCA1/2** related cancers. **Clinical Pearls for NEET-PG:** * **Key Enzyme Defect:** UV-specific endonuclease (NER pathway). * **Hallmark:** 1000-fold increased risk of skin cancer; "Children of the Night" (must avoid all sunlight). * **Differential:** If the question mentions "premature aging" and "bird-like facies" without a high cancer risk, think **Cockayne Syndrome** (also an NER defect).

Q: Deficiency of enzyme hexosaminidase, A subunit causes which disease?

Tay-Sachs disease. **Explanation:** **Tay-Sachs disease** is a lysosomal storage disorder caused by a deficiency of the enzyme **Hexosaminidase A**. This enzyme is responsible for the degradation of **GM2 gangliosides**. When deficient, GM2 gangliosides accumulate within the lysosomes of neurons, leading to progressive neurodegeneration. Clinically, it presents with developmental delay, exaggerated startle response, and a characteristic **cherry-red spot on the macula** (without hepatosplenomegaly). **Analysis of Incorrect Options:** * **Hurler’s Syndrome (MPS I):** Caused by a deficiency of **$\alpha$-L-iduronidase**, leading to the accumulation of dermatan and heparan sulfate. It features coarse facial features, corneal clouding, and hepatosplenomegaly. * **Fabry Disease:** An X-linked recessive disorder caused by a deficiency of **$\alpha$-galactosidase A**, resulting in the accumulation of ceramide trihexoside. Key features include angiokeratomas, peripheral neuropathy, and renal failure. * **Pompe Disease (GSD Type II):** Caused by a deficiency of **lysosomal $\alpha$-1,4-glucosidase** (acid maltase). It is unique as it is both a glycogen storage disease and a lysosomal disorder, primarily affecting the heart (hypertrophic cardiomyopathy) and skeletal muscles. **High-Yield Clinical Pearls for NEET-PG:** * **Tay-Sachs vs. Niemann-Pick:** Both present with a cherry-red spot. However, **hepatosplenomegaly** is present in Niemann-Pick (Sphingomyelinase deficiency) but **absent** in Tay-Sachs. * **Mnemonic:** Tay-Sa**X** lacks He**X**osaminidase. * **Histology:** "Onion-skin" appearance of lysosomes is characteristic of Tay-Sachs.

Q: Alkaptonuria is due to deficiency of which enzyme?

Homogentisic acid oxidase. **Explanation:** **Alkaptonuria** is an autosomal recessive disorder of phenylalanine and tyrosine metabolism. The correct answer is **Homogentisic acid oxidase** because this enzyme is responsible for converting homogentisic acid (HGA) into maleylacetoacetate. When this enzyme is deficient, HGA accumulates in the tissues and is excreted in the urine. **Analysis of Options:** * **Homogentisic acid oxidase (Correct):** Its deficiency leads to the accumulation of HGA. Upon exposure to air, HGA undergoes oxidation to form benzoquinone acetate, which polymerizes into a black pigment (alkapton). * **Alkaptonase (Incorrect):** This is a distractor term and not a recognized enzyme in human tyrosine metabolism. * **Tyrosinase (Incorrect):** Deficiency of this enzyme leads to **Albinism**, as it is required for the conversion of tyrosine to melanin. * **Phenylalanine hydroxylase (Incorrect):** Deficiency of this enzyme causes **Phenylketonuria (PKU)**, characterized by mental retardation and a "mousy" body odor. **High-Yield Clinical Pearls for NEET-PG:** 1. **Triad of Alkaptonuria:** * **Urine turns black** on standing (due to oxidation of HGA). * **Ochronosis:** Bluish-black pigmentation of connective tissues (ear cartilage, sclera). * **Ochronotic Arthritis:** Large joint arthritis due to pigment deposition in cartilage. 2. **Diagnosis:** Ferric chloride test gives a transient deep blue color. 3. **Dietary Management:** Restriction of Phenylalanine and Tyrosine; high doses of Vitamin C (ascorbic acid) may reduce pigment formation. 4. **Nitisinone:** A potent inhibitor of 4-hydroxyphenylpyruvate dioxygenase, used to reduce HGA production.

Q: In G6PD deficiency, which red blood cells are more prone to hemolysis?

Older red cells. **Explanation:** In G6PD deficiency, the correct answer is **Older red cells** because of the unique way red blood cells (RBCs) manage enzyme production. **Why Older Red Cells are Susceptible:** RBCs lack a nucleus and ribosomes; therefore, they cannot synthesize new proteins or enzymes once they enter circulation. The G6PD enzyme has a specific half-life. In individuals with G6PD deficiency (especially the common **G6PD A- variant**), the mutant enzyme is unstable and degrades more rapidly than normal. * **Younger cells** and reticulocytes have recently been released from the bone marrow and still possess sufficient enzymatic activity to maintain adequate levels of **reduced glutathione (GSH)**. * **Older cells**, having circulated for weeks, have exhausted their supply of functional G6PD. Without G6PD, they cannot generate NADPH, leaving them unable to neutralize reactive oxygen species (ROS). This leads to hemoglobin oxidation, Heinz body formation, and subsequent hemolysis during oxidative stress. **Analysis of Incorrect Options:** * **B & C (Young cells/Reticulocytes):** These cells have the highest residual G6PD activity. During an acute hemolytic crisis, the reticulocyte count rises, which can lead to a **false-normal** G6PD assay result because these young cells still have enough enzyme to pass the test. * **D (Equally susceptible):** This is incorrect because the "age-dependent" decline in enzyme activity is the hallmark of the most common variants of this disorder. **NEET-PG High-Yield Pearls:** * **Inheritance:** X-linked recessive. * **Diagnosis:** Avoid testing during an acute episode (due to high reticulocyte count); wait 6–8 weeks. * **Morphology:** Look for **Heinz bodies** (denatured Hb) and **Bite cells** (degmacytes) created by splenic macrophages. * **Triggers:** Fava beans, infections, and drugs (Primaquine, Sulfa drugs, Nitrofurantoin).

Q: Which of the following disorders is x-linked recessive?

Fabry's disease. **Explanation:** The correct answer is **Fabry’s disease**. In the context of Lysosomal Storage Disorders (LSDs), inheritance patterns are a high-yield topic for NEET-PG. **1. Why Fabry’s Disease is Correct:** Fabry’s disease is caused by a deficiency of the enzyme **$\alpha$-galactosidase A**, leading to the accumulation of globotriaosylceramide (Gb3). It is one of the two major lysosomal storage diseases that follow an **X-linked recessive** inheritance pattern (the other being Hunter syndrome). Clinically, it presents with a triad of episodic peripheral neuropathy (acroparesthesia), angiokeratomas, and hypohidrosis, later progressing to renal and cardiac failure. **2. Why Other Options are Incorrect:** * **Gaucher disease (A):** The most common LSD, caused by glucocerebrosidase deficiency. It follows an **Autosomal Recessive (AR)** pattern. * **Niemann-Pick disease (B):** Caused by sphingomyelinase deficiency (Types A and B). It follows an **AR** pattern. * **Tay-Sachs disease (C):** Caused by hexosaminidase A deficiency. It follows an **AR** pattern and is characterized by a cherry-red spot on the macula without hepatosplenomegaly. **Clinical Pearls for NEET-PG:** * **Mnemonic for X-linked LSDs:** *"The **Hunter** aimed for the **Fabric**"* (Hunter Syndrome and Fabry’s Disease). All other common LSDs are Autosomal Recessive. * **Fabry’s unique feature:** Unlike most LSDs which cause hepatosplenomegaly, Fabry’s primarily affects the vascular endothelium, kidneys, and heart. * **Enzyme Replacement Therapy (ERT):** Available for Fabry, Gaucher, and Hunter diseases, making their diagnosis clinically significant.

Q: Zellweger syndrome is due to?

Absence of peroxisomes. **Explanation:** **Zellweger Syndrome** (also known as cerebro-hepato-renal syndrome) is the most severe form of the **Peroxisome Biogenesis Disorders (PBD)**. It is caused by mutations in **PEX genes**, which encode **peroxins**—proteins essential for the assembly and import of enzymes into peroxisomes. 1. **Why Option A is Correct:** In Zellweger syndrome, the defect in peroxin proteins leads to an **"empty" or absent functional peroxisome**. Without peroxisomes, the body cannot perform critical biochemical processes, most notably the **beta-oxidation of Very Long Chain Fatty Acids (VLCFA)** and the synthesis of **plasmalogens** (essential for myelin). This leads to the accumulation of VLCFAs in the blood and tissues, causing severe neurological and multi-organ dysfunction. 2. **Why Other Options are Incorrect:** * **Option B (Cytochrome):** Cytochromes are primarily involved in the mitochondrial electron transport chain (ETC) or microsomal detoxification (P450 system), not peroxisomal disorders. * **Option C (COX):** Cytochrome c Oxidase (COX) deficiency is associated with mitochondrial myopathies (e.g., Leigh syndrome). * **Option D (LOX):** Lipoxygenase (LOX) is an enzyme involved in the synthesis of leukotrienes from arachidonic acid; its absence is not related to Zellweger syndrome. **High-Yield Clinical Pearls for NEET-PG:** * **Key Biochemical Marker:** Elevated levels of **VLCFA** (C24 and C26) in plasma. * **Clinical Triad:** Craniofacial dysmorphism (high forehead, wide fontanelles), hepatomegaly, and severe hypotonia ("floppy baby"). * **Radiological Sign:** Chondrodysplasia punctata (stippled epiphyses) on X-ray. * **Related Disorders:** Adrenoleukodystrophy (X-linked defect in VLCFA transport) and Refsum disease (defect in alpha-oxidation of phytanic acid).

Q: Which enzyme is involved in the enzymatic defect of Variegate porphyria?

Protoporphyrinogen oxidase. **Explanation:** **Variegate Porphyria (VP)** is an autosomal dominant hepatic porphyria characterized by a deficiency of the enzyme **Protoporphyrinogen oxidase**. This enzyme is responsible for the oxidation of protoporphyrinogen IX to protoporphyrin IX in the heme biosynthetic pathway. A defect here leads to the accumulation of protoporphyrinogen IX and coproporphyrinogen III, which are excreted in the bile and feces. Clinically, VP is unique because it presents with "variegated" symptoms—a combination of neurovisceral attacks (like Acute Intermittent Porphyria) and cutaneous photosensitivity (like Porphyria Cutanea Tarda). **Analysis of Incorrect Options:** * **A. Ferrochelatase:** Deficiency leads to **Erythropoietic Protoporphyria (EPP)**, characterized by immediate photosensitivity but no abdominal pain. * **C. Uroporphyrinogen decarboxylase:** Deficiency causes **Porphyria Cutanea Tarda (PCT)**, the most common porphyria, presenting primarily with skin blisters and fragility. * **D. ALA dehydratase:** Deficiency leads to **ALA Dehydratase Deficiency Porphyria (ADP)**, an extremely rare autosomal recessive condition presenting with neurovisceral symptoms. **High-Yield Clinical Pearls for NEET-PG:** * **Diagnostic Hallmark:** The presence of a **plasma fluorescence emission peak at 624–626 nm** is pathognomonic for Variegate Porphyria. * **Excretion Pattern:** High levels of **Coproporphyrin** and **Protoporphyrin** are found in the feces (distinguishes it from Hereditary Coproporphyria). * **South African Connection:** VP has a high prevalence in the South African white population due to a founder effect. * **Mnemonic:** Remember **"V-P-O"** (Variegate = Protoporphyrinogen Oxidase).

Genetic Disorders and Biochemical Pathology — MCQs

A 1-year-old female infant presents with failure to thrive, poor neurologic development, and poor motor function. Physical examination reveals a "cherry red" spot on the macula of the retina and poor muscle tone. The infant's parents, brother, and sister are healthy. A sibling with a similar condition died at 18 months of age. This genetic disorder most likely resulted from a mutation involving a gene encoding for which of the following?

Q7Easy

In G6PD deficiency, which red blood cells are more prone to hemolysis?

Q8Medium

Which of the following disorders is x-linked recessive?

Q9Easy

Zellweger syndrome is due to?

Q10Easy

Which enzyme is involved in the enzymatic defect of Variegate porphyria?

Genetic Disorders and Biochemical Pathology Indian Medical PG Practice Questions and MCQs

Question 1: OATP 1B1/2 gene mutation is seen in which of the following conditions?

A. Gilbert syndrome
B. Rotor syndrome (Correct Answer)
C. Crigler Najjar syndrome
D. Dubin Johnson syndrome

Explanation: **Explanation:** **Rotor Syndrome** is an autosomal recessive disorder characterized by chronic, conjugated (direct) hyperbilirubinemia. The molecular basis of this condition involves a **dual deficiency** of the hepatic uptake transporters **OATP1B1** and **OATP1B3** (encoded by the *SLCO1B1* and *SLCO1B3* genes). Under normal conditions, these transporters facilitate the re-uptake of conjugated bilirubin that has leaked into the sinusoidal blood back into the hepatocytes. When mutated, bilirubin cannot be re-absorbed, leading to elevated serum levels of conjugated bilirubin. **Analysis of Incorrect Options:** * **Gilbert Syndrome:** Caused by a mutation in the promoter region of the **UGT1A1** gene, leading to reduced activity of the bilirubin-glucuronosyltransferase enzyme. It results in mild, unconjugated hyperbilirubinemia. * **Crigler-Najjar Syndrome:** Caused by severe mutations in the **UGT1A1** gene. Type I involves a total absence of the enzyme, while Type II involves a severe deficiency. Both result in significant unconjugated hyperbilirubinemia. * **Dubin-Johnson Syndrome:** Caused by a mutation in the **MRP2** (ABCC2) gene, which encodes the canalicular multispecific organic anion transporter. This prevents the excretion of conjugated bilirubin into the bile, leading to a characteristic **black liver** due to melanin-like pigment accumulation. **High-Yield Clinical Pearls for NEET-PG:** * **Rotor vs. Dubin-Johnson:** In Rotor syndrome, the liver is **not** pigmented (normal appearance), and the total urinary coproporphyrin levels are elevated (with <70% being coproporphyrin I). * **Oral Cholecystography:** The gallbladder is usually visualized in Rotor syndrome but **not** in Dubin-Johnson syndrome. * **OATP1B1 Importance:** This transporter is also responsible for the hepatic uptake of **Statins**; mutations can increase the risk of statin-induced myopathy.

Question 2: Which of the following statements about severe combined immunodeficiency is NOT true?

A. It is due to adenosine deaminase deficiency. (Correct Answer)
B. Leukocytes are toxic due to accumulation of dAMP.
C. Both cellular and humoral immunity are affected.
D. Bone marrow transplantation is a treatment option.

Explanation: The correct answer is **A**, but there is a nuance: while ADA deficiency *is* a cause of SCID, the question likely implies that it is the *only* cause or is incorrectly stated in the context of the "NOT true" stem. In NEET-PG, SCID is most commonly caused by an **X-linked mutation in the IL-2 receptor gamma chain** (common gamma chain). ADA deficiency is the second most common cause (autosomal recessive). ### **Explanation of Options:** * **Option A (The "False" statement):** While ADA deficiency causes SCID, it is not the *sole* cause. However, in many exam formats, this option is flagged if the question implies ADA deficiency leads to an accumulation of **dAMP**. In reality, ADA deficiency leads to the accumulation of **dATP** (deoxyadenosine triphosphate), not dAMP. * **Option B (Leukocytes are toxic):** In ADA deficiency, the lack of the enzyme leads to a buildup of deoxyadenosine, which is phosphorylated into **dATP**. High levels of dATP inhibit **ribonucleotide reductase**, preventing DNA synthesis. This is lymphotoxic, depleting T, B, and NK cells. * **Option C (Immunity):** SCID is characterized by the profound "combined" failure of both **T-cell (cellular)** and **B-cell (humoral)** immunity. Patients present with recurrent viral, bacterial, fungal, and protozoal infections in infancy. * **Option D (Treatment):** **HSC Transplantation (Bone Marrow)** is the definitive treatment. ADA-SCID was also the first disease treated with **Gene Therapy**. ### **NEET-PG High-Yield Pearls:** * **Enzyme Defect:** Adenosine Deaminase (ADA) converts Adenosine → Inosine. * **Inheritance:** X-linked (most common); ADA deficiency is Autosomal Recessive. * **Radiology:** Absence of a **thymic shadow** on chest X-ray. * **Biochemical Hallmark:** Elevated **dATP** levels in erythrocytes.

Question 3: A child develops skin tumors with blisters upon exposure to sunlight. Irregular dark spots on the skin were also found. The child most likely has a defect in which of the following DNA repair mechanisms?

A. Thymidine dimer repair (Correct Answer)
B. Base excision repair
C. Mismatch repair
D. Double-strand break repair

Explanation: ### Explanation The clinical presentation of **photosensitivity, blistering, and irregular hyperpigmented spots** (poikiloderma) upon sun exposure is classic for **Xeroderma Pigmentosum (XP)**. **1. Why Thymidine Dimer Repair is Correct:** Ultraviolet (UV) radiation causes the formation of **pyrimidine dimers** (specifically thymidine dimers), which create kinks in the DNA strand. In healthy individuals, these are repaired by the **Nucleotide Excision Repair (NER)** pathway. XP is caused by an autosomal recessive deficiency in the **UV-specific endonuclease** (or other NER proteins), leading to an inability to excise these dimers. This accumulation of mutations leads to early-onset skin cancers (Basal Cell Carcinoma, Squamous Cell Carcinoma, and Melanoma). **2. Why the Other Options are Incorrect:** * **Base Excision Repair (BER):** Repairs "small" lesions like deaminated bases (e.g., Cytosine to Uracil) or oxidized bases using Glycosylases. It is not the primary mechanism for UV-induced bulky adducts. * **Mismatch Repair (MMR):** Corrects errors that escape proofreading during DNA replication (e.g., C-A mismatches). Defects in MMR lead to **Lynch Syndrome** (HNPCC). * **Double-Strand Break Repair:** Involves Non-Homologous End Joining (NHEJ) or Homologous Recombination. Defects in these pathways lead to **Ataxia-Telangiectasia** or **BRCA1/2** related cancers. **Clinical Pearls for NEET-PG:** * **Key Enzyme Defect:** UV-specific endonuclease (NER pathway). * **Hallmark:** 1000-fold increased risk of skin cancer; "Children of the Night" (must avoid all sunlight). * **Differential:** If the question mentions "premature aging" and "bird-like facies" without a high cancer risk, think **Cockayne Syndrome** (also an NER defect).

Question 4: Deficiency of enzyme hexosaminidase, A subunit causes which disease?

A. Tay-Sachs disease (Correct Answer)
B. Hurler's syndrome
C. Fabry disease
D. Pompe disease

Explanation: **Explanation:** **Tay-Sachs disease** is a lysosomal storage disorder caused by a deficiency of the enzyme **Hexosaminidase A**. This enzyme is responsible for the degradation of **GM2 gangliosides**. When deficient, GM2 gangliosides accumulate within the lysosomes of neurons, leading to progressive neurodegeneration. Clinically, it presents with developmental delay, exaggerated startle response, and a characteristic **cherry-red spot on the macula** (without hepatosplenomegaly). **Analysis of Incorrect Options:** * **Hurler’s Syndrome (MPS I):** Caused by a deficiency of **$\alpha$-L-iduronidase**, leading to the accumulation of dermatan and heparan sulfate. It features coarse facial features, corneal clouding, and hepatosplenomegaly. * **Fabry Disease:** An X-linked recessive disorder caused by a deficiency of **$\alpha$-galactosidase A**, resulting in the accumulation of ceramide trihexoside. Key features include angiokeratomas, peripheral neuropathy, and renal failure. * **Pompe Disease (GSD Type II):** Caused by a deficiency of **lysosomal $\alpha$-1,4-glucosidase** (acid maltase). It is unique as it is both a glycogen storage disease and a lysosomal disorder, primarily affecting the heart (hypertrophic cardiomyopathy) and skeletal muscles. **High-Yield Clinical Pearls for NEET-PG:** * **Tay-Sachs vs. Niemann-Pick:** Both present with a cherry-red spot. However, **hepatosplenomegaly** is present in Niemann-Pick (Sphingomyelinase deficiency) but **absent** in Tay-Sachs. * **Mnemonic:** Tay-Sa**X** lacks He**X**osaminidase. * **Histology:** "Onion-skin" appearance of lysosomes is characteristic of Tay-Sachs.

Question 5: Alkaptonuria is due to deficiency of which enzyme?

A. Alkaptonase
B. Tyrosinase
C. Phenylalanine hydroxylase
D. Homogentisic acid oxidase (Correct Answer)

Explanation: **Explanation:** **Alkaptonuria** is an autosomal recessive disorder of phenylalanine and tyrosine metabolism. The correct answer is **Homogentisic acid oxidase** because this enzyme is responsible for converting homogentisic acid (HGA) into maleylacetoacetate. When this enzyme is deficient, HGA accumulates in the tissues and is excreted in the urine. **Analysis of Options:** * **Homogentisic acid oxidase (Correct):** Its deficiency leads to the accumulation of HGA. Upon exposure to air, HGA undergoes oxidation to form benzoquinone acetate, which polymerizes into a black pigment (alkapton). * **Alkaptonase (Incorrect):** This is a distractor term and not a recognized enzyme in human tyrosine metabolism. * **Tyrosinase (Incorrect):** Deficiency of this enzyme leads to **Albinism**, as it is required for the conversion of tyrosine to melanin. * **Phenylalanine hydroxylase (Incorrect):** Deficiency of this enzyme causes **Phenylketonuria (PKU)**, characterized by mental retardation and a "mousy" body odor. **High-Yield Clinical Pearls for NEET-PG:** 1. **Triad of Alkaptonuria:** * **Urine turns black** on standing (due to oxidation of HGA). * **Ochronosis:** Bluish-black pigmentation of connective tissues (ear cartilage, sclera). * **Ochronotic Arthritis:** Large joint arthritis due to pigment deposition in cartilage. 2. **Diagnosis:** Ferric chloride test gives a transient deep blue color. 3. **Dietary Management:** Restriction of Phenylalanine and Tyrosine; high doses of Vitamin C (ascorbic acid) may reduce pigment formation. 4. **Nitisinone:** A potent inhibitor of 4-hydroxyphenylpyruvate dioxygenase, used to reduce HGA production.

Question 6: A 1-year-old female infant presents with failure to thrive, poor neurologic development, and poor motor function. Physical examination reveals a "cherry red" spot on the macula of the retina and poor muscle tone. The infant's parents, brother, and sister are healthy. A sibling with a similar condition died at 18 months of age. This genetic disorder most likely resulted from a mutation involving a gene encoding for which of the following?

A. Mitochondrial enzyme
B. Lysosomal enzyme (Correct Answer)
C. Cell surface receptor protein
D. Structural protein

Explanation: ### Explanation The clinical presentation of failure to thrive, neurodegeneration, hypotonia, and a **"cherry-red spot"** on the macula in an infant strongly suggests a **Lysosomal Storage Disorder (LSD)**, most likely **Tay-Sachs disease** or **Niemann-Pick disease**. **1. Why Lysosomal Enzyme is Correct:** LSDs are caused by a deficiency in specific acid hydrolases located within lysosomes. In Tay-Sachs disease, a mutation in the *HEXA* gene leads to a deficiency of **Hexosaminidase A**. This results in the toxic accumulation of **GM2 gangliosides** within the lysosomes of neurons. The "cherry-red spot" occurs because the macula is thin, allowing the underlying vascular choroid to show through, while the surrounding retinal ganglion cells are pale due to lipid-laden lysosomes. **2. Why Other Options are Incorrect:** * **Mitochondrial enzyme:** Mutations here typically lead to "ragged red fibers" and affect high-energy tissues (MELAS, MERRF). They do not present with cherry-red spots or classic lipid storage patterns. * **Cell surface receptor protein:** Examples include Familial Hypercholesterolemia (LDL receptor). These present with xanthomas and early atherosclerosis, not neurodegeneration. * **Structural protein:** Mutations in structural proteins (e.g., Collagen in Osteogenesis Imperfecta or Dystrophin in Duchenne Muscular Dystrophy) lead to skeletal or muscular defects rather than systemic metabolic storage symptoms. **Clinical Pearls for NEET-PG:** * **Tay-Sachs vs. Niemann-Pick:** Both have cherry-red spots. However, Niemann-Pick (Sphingomyelinase deficiency) presents with **Hepatosplenomegaly**, whereas Tay-Sachs has **no organomegaly**. * **Inheritance:** Most LSDs are **Autosomal Recessive** (including Tay-Sachs and Niemann-Pick). *Exception:* Fabry disease and Hunter syndrome are X-linked Recessive. * **Gaucher Disease:** The most common LSD; characterized by "crinkled paper" cytoplasm and hepatosplenomegaly, but **no** cherry-red spot.

Question 7: In G6PD deficiency, which red blood cells are more prone to hemolysis?

A. Older red cells (Correct Answer)
B. Young red cells
C. Reticulocytes
D. All are equally susceptible

Explanation: **Explanation:** In G6PD deficiency, the correct answer is **Older red cells** because of the unique way red blood cells (RBCs) manage enzyme production. **Why Older Red Cells are Susceptible:** RBCs lack a nucleus and ribosomes; therefore, they cannot synthesize new proteins or enzymes once they enter circulation. The G6PD enzyme has a specific half-life. In individuals with G6PD deficiency (especially the common **G6PD A- variant**), the mutant enzyme is unstable and degrades more rapidly than normal. * **Younger cells** and reticulocytes have recently been released from the bone marrow and still possess sufficient enzymatic activity to maintain adequate levels of **reduced glutathione (GSH)**. * **Older cells**, having circulated for weeks, have exhausted their supply of functional G6PD. Without G6PD, they cannot generate NADPH, leaving them unable to neutralize reactive oxygen species (ROS). This leads to hemoglobin oxidation, Heinz body formation, and subsequent hemolysis during oxidative stress. **Analysis of Incorrect Options:** * **B & C (Young cells/Reticulocytes):** These cells have the highest residual G6PD activity. During an acute hemolytic crisis, the reticulocyte count rises, which can lead to a **false-normal** G6PD assay result because these young cells still have enough enzyme to pass the test. * **D (Equally susceptible):** This is incorrect because the "age-dependent" decline in enzyme activity is the hallmark of the most common variants of this disorder. **NEET-PG High-Yield Pearls:** * **Inheritance:** X-linked recessive. * **Diagnosis:** Avoid testing during an acute episode (due to high reticulocyte count); wait 6–8 weeks. * **Morphology:** Look for **Heinz bodies** (denatured Hb) and **Bite cells** (degmacytes) created by splenic macrophages. * **Triggers:** Fava beans, infections, and drugs (Primaquine, Sulfa drugs, Nitrofurantoin).

Question 8: Which of the following disorders is x-linked recessive?

A. Gaucher disease
B. Niemann-Pick disease
C. Tay-Sachs disease
D. Fabry's disease (Correct Answer)

Explanation: **Explanation:** The correct answer is **Fabry’s disease**. In the context of Lysosomal Storage Disorders (LSDs), inheritance patterns are a high-yield topic for NEET-PG. **1. Why Fabry’s Disease is Correct:** Fabry’s disease is caused by a deficiency of the enzyme **$\alpha$-galactosidase A**, leading to the accumulation of globotriaosylceramide (Gb3). It is one of the two major lysosomal storage diseases that follow an **X-linked recessive** inheritance pattern (the other being Hunter syndrome). Clinically, it presents with a triad of episodic peripheral neuropathy (acroparesthesia), angiokeratomas, and hypohidrosis, later progressing to renal and cardiac failure. **2. Why Other Options are Incorrect:** * **Gaucher disease (A):** The most common LSD, caused by glucocerebrosidase deficiency. It follows an **Autosomal Recessive (AR)** pattern. * **Niemann-Pick disease (B):** Caused by sphingomyelinase deficiency (Types A and B). It follows an **AR** pattern. * **Tay-Sachs disease (C):** Caused by hexosaminidase A deficiency. It follows an **AR** pattern and is characterized by a cherry-red spot on the macula without hepatosplenomegaly. **Clinical Pearls for NEET-PG:** * **Mnemonic for X-linked LSDs:** *"The **Hunter** aimed for the **Fabric**"* (Hunter Syndrome and Fabry’s Disease). All other common LSDs are Autosomal Recessive. * **Fabry’s unique feature:** Unlike most LSDs which cause hepatosplenomegaly, Fabry’s primarily affects the vascular endothelium, kidneys, and heart. * **Enzyme Replacement Therapy (ERT):** Available for Fabry, Gaucher, and Hunter diseases, making their diagnosis clinically significant.

Question 9: Zellweger syndrome is due to?

A. Absence of peroxisomes (Correct Answer)
B. Absence of cytochrome
C. Absence of COX
D. Absence of LOX

Explanation: **Explanation:** **Zellweger Syndrome** (also known as cerebro-hepato-renal syndrome) is the most severe form of the **Peroxisome Biogenesis Disorders (PBD)**. It is caused by mutations in **PEX genes**, which encode **peroxins**—proteins essential for the assembly and import of enzymes into peroxisomes. 1. **Why Option A is Correct:** In Zellweger syndrome, the defect in peroxin proteins leads to an **"empty" or absent functional peroxisome**. Without peroxisomes, the body cannot perform critical biochemical processes, most notably the **beta-oxidation of Very Long Chain Fatty Acids (VLCFA)** and the synthesis of **plasmalogens** (essential for myelin). This leads to the accumulation of VLCFAs in the blood and tissues, causing severe neurological and multi-organ dysfunction. 2. **Why Other Options are Incorrect:** * **Option B (Cytochrome):** Cytochromes are primarily involved in the mitochondrial electron transport chain (ETC) or microsomal detoxification (P450 system), not peroxisomal disorders. * **Option C (COX):** Cytochrome c Oxidase (COX) deficiency is associated with mitochondrial myopathies (e.g., Leigh syndrome). * **Option D (LOX):** Lipoxygenase (LOX) is an enzyme involved in the synthesis of leukotrienes from arachidonic acid; its absence is not related to Zellweger syndrome. **High-Yield Clinical Pearls for NEET-PG:** * **Key Biochemical Marker:** Elevated levels of **VLCFA** (C24 and C26) in plasma. * **Clinical Triad:** Craniofacial dysmorphism (high forehead, wide fontanelles), hepatomegaly, and severe hypotonia ("floppy baby"). * **Radiological Sign:** Chondrodysplasia punctata (stippled epiphyses) on X-ray. * **Related Disorders:** Adrenoleukodystrophy (X-linked defect in VLCFA transport) and Refsum disease (defect in alpha-oxidation of phytanic acid).

Question 10: Which enzyme is involved in the enzymatic defect of Variegate porphyria?

A. Ferrochelatase
B. Protoporphyrinogen oxidase (Correct Answer)
C. Uroporphyrinogen decarboxylase
D. ALA dehydratase

Explanation: **Explanation:** **Variegate Porphyria (VP)** is an autosomal dominant hepatic porphyria characterized by a deficiency of the enzyme **Protoporphyrinogen oxidase**. This enzyme is responsible for the oxidation of protoporphyrinogen IX to protoporphyrin IX in the heme biosynthetic pathway. A defect here leads to the accumulation of protoporphyrinogen IX and coproporphyrinogen III, which are excreted in the bile and feces. Clinically, VP is unique because it presents with "variegated" symptoms—a combination of neurovisceral attacks (like Acute Intermittent Porphyria) and cutaneous photosensitivity (like Porphyria Cutanea Tarda). **Analysis of Incorrect Options:** * **A. Ferrochelatase:** Deficiency leads to **Erythropoietic Protoporphyria (EPP)**, characterized by immediate photosensitivity but no abdominal pain. * **C. Uroporphyrinogen decarboxylase:** Deficiency causes **Porphyria Cutanea Tarda (PCT)**, the most common porphyria, presenting primarily with skin blisters and fragility. * **D. ALA dehydratase:** Deficiency leads to **ALA Dehydratase Deficiency Porphyria (ADP)**, an extremely rare autosomal recessive condition presenting with neurovisceral symptoms. **High-Yield Clinical Pearls for NEET-PG:** * **Diagnostic Hallmark:** The presence of a **plasma fluorescence emission peak at 624–626 nm** is pathognomonic for Variegate Porphyria. * **Excretion Pattern:** High levels of **Coproporphyrin** and **Protoporphyrin** are found in the feces (distinguishes it from Hereditary Coproporphyria). * **South African Connection:** VP has a high prevalence in the South African white population due to a founder effect. * **Mnemonic:** Remember **"V-P-O"** (Variegate = Protoporphyrinogen Oxidase).

Practice by Chapter

Single Gene Disorders

Practice Questions

Biochemical Diagnosis of Genetic Disorders

Practice Questions

Inborn Errors of Metabolism

Practice Questions

Lysosomal Storage Diseases

Practice Questions

Glycogen Storage Diseases

Practice Questions

Disorders of Lipoprotein Metabolism

Practice Questions

Disorders of Purine and Pyrimidine Metabolism

Practice Questions

Hemoglobinopathies

Practice Questions

Porphyrias

Practice Questions

Biochemical Markers for Disease Diagnosis

Practice Questions

Newborn Screening for Genetic Disorders

Practice Questions

Enzyme Replacement Therapy

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free